From: Glycopeptide antibiotic drug stability in aqueous solution
Generic names | Trade names | Commercial source | Dosage forms | Shelf life and storage cond. | pH (adj. agent) | Product Information |
---|---|---|---|---|---|---|
Vancomycin | VANCOCIN VANCOMYCIN HCl Pulvules Firvanq | AMI Pharmaceuticals, Inc. (VANCOCIN capsules) Mylan Institutional, LLC (VANCOMYCIN HCL powder) | Capsule, powder for oral, powder for injection, and injection solution | 2 y at 2–8 °C | 2.5–5.5 (HCl or NaOH) | |
Telavancin | VIBATIV | Theravance Biopharma, Inc. | Powder for injection | 3 y at 2–8 °C | 4.0–5.0 | [23] |
Dalbavacin | DALVANCE | Allergan Pharmaceutical Company (Durata Therapeutics Inc.), Vicuron Pharmaceuticals LLC | Powder for injection | 3 y at up to 25 °C | 4–5 (NaOH or HCl) | |
Oritavancin | ORVACTIV | Melinta Therapeutics | Powder for injection | 3 y at up to 25 °C | 3.1–4.3 (H3PO4) | [26] |
Teicoplanin | TARGOCID (European Market only) | Sanofi–Aventis | Powder for injection | 3 y at 2–8 °C | 7.2–7.8 (NaOH) | [27] |